1061983 - Cytokinetics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CYTK (1061983)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
47 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S1+2+7-14+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-02
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerM - OptEx$6.53+1,35515,000+10%+$8,850
D
2017-11-02
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale+OE$12.94-4,26015,000-22%-$55,134
D
2017-11-01
CYTKMalik Fady IbrahamEVP Research, DevelopmentM - OptEx$11.10+6,66646,191+17%+$73,993
D
2017-11-01
CYTKMalik Fady IbrahamEVP Research, DevelopmentS - Sale+OE$13.39-7,32146,191-14%-$98,046
2017-11-01
CYTKBlum Robert IPres, CEOS - Sale$13.51-5,00069,846-7%-$67,553
D
2017-10-06
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerM - OptEx$6.51+11,58316,771+223%+$75,352
D
2017-10-06
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale+OE$15.49-13,18116,771-44%-$204,162
D
2017-10-02
CYTKGage L PatrickDirM - OptEx$4.02+5,00031,850+19%+$20,100
D
2017-10-02
CYTKGage L PatrickDirS - Sale+OE$14.59-5,00031,850-14%-$72,944
2017-10-02
CYTKBlum Robert IPres, CEOS - Sale$14.59-5,00074,051-6%-$72,957
D
2017-09-06
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale+OE$15.00-10018,369-1%-$1,500
2017-09-06
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerM - OptEx$6.50+10,23118,469+124%+$66,521
2017-09-06
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale$14.60-10,13118,469-35%-$147,864
D
2017-09-01
CYTKGage L PatrickDirM - OptEx$4.02+5,00031,850+19%+$20,100
D
2017-09-01
CYTKGage L PatrickDirS - Sale+OE$14.72-5,00031,850-14%-$73,623
2017-09-01
CYTKBlum Robert IPres, CEOS - Sale$14.71-5,00079,051-6%-$73,528
D
2017-08-31
CYTKCosta Santo JDirM - OptEx$4.44+5,0000-100%+$22,200
D
2017-08-31
CYTKCosta Santo JDirS - Sale+OE$15.00-5,0000-100%-$75,000
D
2017-08-31
CYTKMorgan Bradley PaulSVP Drug Discovery, Early DevM - OptEx$7.84+118,33046,441-165%+$927,943
D
2017-08-31
CYTKMorgan Bradley PaulSVP Drug Discovery, Early DevS - Sale+OE$15.00-118,33046,441-72%-$1,774,950
D
2017-08-29
CYTKGage L PatrickDirM - OptEx$4.02+5,00031,850+19%+$20,100
D
2017-08-29
CYTKGage L PatrickDirS - Sale+OE$14.00-5,00031,850-14%-$70,000
D
2017-08-29
CYTKCosta Santo JDirM - OptEx$4.44+5,0000-100%+$22,200
D
2017-08-29
CYTKCosta Santo JDirS - Sale+OE$14.00-5,0000-100%-$70,000
D
2017-08-08
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerM - OptEx$6.50+9,53818,369+108%+$61,995
D
2017-08-08
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale+OE$12.47-11,34818,369-38%-$141,467
2017-08-01
CYTKBlum Robert IPres, CEOS - Sale$13.79-5,00084,051-6%-$68,949
2017-07-03
CYTKBlum Robert IPres, CEOS - Sale$12.14-5,00089,051-5%-$60,693
2017-06-01
CYTKBlum Robert IPres, CEOS - Sale$13.62-5,00094,051-5%-$68,093
D
2017-02-28
CYTKWolff Andrew ASVP, CMOA - Grant$0.00+27,50047,255+139%+$28+4+11+15
D
2017-02-28
CYTKWolff Andrew ASVP, CMOF - Tax$10.60-4,98447,255-10%-$52,830+4+11+15
2017-02-28
CYTKBarbari Sharon SurreyEVP, Finance, CFOA - Grant$0.00+18,75040,323+87%+$19+4+11+15
2017-02-28
CYTKBarbari Sharon SurreyEVP, Finance, CFOF - Tax$10.60-7,31740,323-15%-$77,560+4+11+15
D
2017-02-28
CYTKSchnieders ElisabethSVP, Business DevelopmentA - Grant$0.00+32,50043,919+285%+$33+4+11+15
D
2017-02-28
CYTKSchnieders ElisabethSVP, Business DevelopmentF - Tax$10.60-5,06643,919-10%-$53,700+4+11+15
D
2017-02-28
CYTKMorgan Bradley PaulSVP Drug Discovery, Early DevA - Grant$0.00+35,00045,194+343%+$35+4+11+15
D
2017-02-28
CYTKMorgan Bradley PaulSVP Drug Discovery, Early DevF - Tax$10.60-5,98645,194-12%-$63,452+4+11+15
D
2017-02-28
CYTKMcDowell Caryn GordonGC, Chief Compliance OfficerA - Grant$0.00+15,00018,581+419%+$15+4+11+15
D
2017-02-28
CYTKMalik Fady IbrahamEVP Research, DevelopmentA - Grant$0.00+55,00045,404-573%+$55+4+11+15
D
2017-02-28
CYTKMalik Fady IbrahamEVP Research, DevelopmentF - Tax$10.60-9,63145,404-17%-$102,089+4+11+15
D
2017-02-28
CYTKCragg DavidSVP HRA - Grant$0.00+35,00048,018+269%+$35+4+11+15
D
2017-02-28
CYTKCragg DavidSVP HRF - Tax$10.60-6,00848,018-11%-$63,685+4+11+15
D
2017-02-28
CYTKCharpentier BonnieSVP Regulatory, ComplianceA - Grant$0.00+35,00029,004-584%+$35+4+11+15
D
2017-02-28
CYTKCharpentier BonnieSVP Regulatory, ComplianceF - Tax$10.60-5,99629,004-17%-$63,558+4+11+15
D
2017-02-28
CYTKBlum Robert IPres, CEOA - Grant$0.00+105,00097,934-1486%+$105+4+11+15
D
2017-02-28
CYTKBlum Robert IPres, CEOF - Tax$10.60-17,00797,934-15%-$180,274+4+11+15
M
2016-12-28
CYTKMalik Fady IbrahamEVP Research, DevelopmentS - Sale$12.36-5,63335-99%-$69,643+2+7-14

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top